BioSkryb Genomics, a Durham company focused on single-cell and ultra-low input multiomics, has introduced a new service called ResolveSEQ MRD, which allows more detailed classification and ...

Patrick Tan to receive Genome Valley Excellence Award at BioAsia for pioneering work in precision medicine and cancer ...

Humanity Protocol is an innovative decentralized identity solution that employs advanced technologies-ranging from palm ...

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for.

Indian healthcare industry keen on paving way for accessible & scalable precision medicine: Nandita Vijayasimha, Bengaluru Wednesday, February 12, 2025, 08:00 Hrs [IST] Indian hea ...

Hyderabad: BioAsia, Asia's largest annual global biotechnology and life sciences forum, announced that the prestigious Genome ...

Agilent Technologies (NYSE:A – Get Free Report) was upgraded by equities researchers at Barclays from an “underweight” rating ...

In a stark reflection of the challenges facing the biotech sector, 10X Genomics Inc (NASDAQ:TXG) stock has tumbled to a 52-week low, touching down at $11.89. According to InvestingPro data, technical ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

Colossal is a firm focused on bioscience and the de-extinction of species like the woolly mammoth and dodo bird.